Amprius technologies director Kang Sun sells $642,186 in stock

Amprius Technologies director Kang Sun sold 62,101 shares for $642,186 to cover tax obligations. The stock is down 4.2% this week. Amprius reported Q2 revenue of $34.02M, beating estimates, and raised its full-year revenue guidance to at least $140M. The company has $74.5M in cash and no debt.

Original reporting
Published Aug 26, 2026, 8:49 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 26, 2026, 12:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$AMPX
Neutral
medium confidence
Mentioned
$AMPX
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$AMPXNeutralMed
01

Why it matters

The combination of insider selling and upgraded guidance creates a nuanced trade case.

02

Market read

Earnings beat and guidance raise are primary catalysts; insider sale adds short‑term nuance.

03

What to watch

Cash balance of $74.5M provides runway; lease extension reduces operational risk.

Relevance 7/10Novelty 8/10Timing: post‑earnings release

Background

Amprius Technologies (AMPX) is a developer of silicon‑anode battery technology.

Company-level read

Ticker impact

$AMPXNeutralMedium confidence
Context

Director Kang Sun sold $642,186 of AMPX stock and the company reported Q2 results with raised full-year revenue guidance to at least $140M.

Expected impact

Potential short-term pressure from the sale, offset by medium-term upside from guidance lift.

Evidence & confidence

The sale size is modest for a microcap, while the guidance increase is material for future earnings expectations.

Market effects

Improves outlook for the advanced battery materials sector.

Limited to U.S. micro‑cap investors.

Low

Counterpoint

Insider sale could foreshadow upcoming challenges despite guidance lift.

Key entities

  • Kang Sun

    Sold 62,101 shares to cover tax obligations.

Related articles

$AMPXMedAI 8/10

Amprius (AMPX) Q3 2026 Earnings Call Transcript

Amprius reported Q3 2026 revenue of $39.1M, up 83% YoY, raising its full-year target to $145M. The company introduced SiCore 500 cells for aviation and secured a $75M U.S. defense contract. Amprius expanded into maritime vehicles and partnered with U.S. manufacturers for NDAA-compliant production.

$AMPXMedAI 8/10

Amprius Technologies Q3 Earnings Call Highlights

Amprius reported a Q3 net loss of $3.5M, with adjusted EBITDA at -$1M. The company maintained its full-year gross margin forecast of 28% and expects Q4 sales of $43.3M. Amprius is expanding manufacturing to meet demand, with a $75M contract for a U.S. battery production line. It also introduced new products for aviation and deep-sea applications, ending Q3 with $60.7M in cash.

$AMPXHigh

Amprius Technologies falls 7% on third quarter earnings miss

Amprius Technologies (NYSE:AMPX) reported Q3 earnings missing estimates with a loss of $0.02 per share, though revenue of $39.1M beat expectations. Shares fell 7.7% after-hours. The company raised its full-year 2026 revenue outlook to $145M, above analyst forecasts. Gross profit rose 217% YoY to $10.5M, with gross margin improving to 27%. Amprius secured a $75M U.S. Department of War contract and introduced a new battery cell.

$AMPXMed

Amprius Technologies Reports Third Quarter 2026 Financial Results and Recent

Amprius Technologies, Inc. (AMPX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Amprius Technologies Reports Third Quarter 2026 Financial Results and Recent Business Highlights • Q3 2026 revenue increased 83% year-over-year to $39.1 million • Net loss of $3.5 million, a 10% year-over-year improvement • Increasing 2026 revenue outlook to $145 mil

$AMPXHigh

AMPX Stock Jumps As Defense Deals Supercharge Growth Story

Amprius Technologies Inc. (NYSE: AMPX) shares rose 8.38% on October 21, 2026, driven by U.S. Department of War funding and a partnership with Caminus for battery production. The company secured $75M in funding for a high-energy-density cell plant, with revenue growth but negative margins. Canaccord Genuity initiated coverage with a Buy rating and $14 price target.